NO951462L - Preparat basert på polyoksyetylen-polyoksypropylenblokk kopolymerer og beholder som inneholder preparatet - Google Patents

Preparat basert på polyoksyetylen-polyoksypropylenblokk kopolymerer og beholder som inneholder preparatet

Info

Publication number
NO951462L
NO951462L NO951462A NO951462A NO951462L NO 951462 L NO951462 L NO 951462L NO 951462 A NO951462 A NO 951462A NO 951462 A NO951462 A NO 951462A NO 951462 L NO951462 L NO 951462L
Authority
NO
Norway
Prior art keywords
preparation
container containing
polyoxyethylene
block copolymers
polyoxypropylene block
Prior art date
Application number
NO951462A
Other languages
English (en)
Other versions
NO951462D0 (no
Inventor
Mary Sou
Craig William Davis
Alison Green Floyd
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO951462D0 publication Critical patent/NO951462D0/no
Publication of NO951462L publication Critical patent/NO951462L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Packages (AREA)

Abstract

Forseglet farmasøytisk akseptabel beholder som i et vakuum eller i en inert atmosfære inneholder en steril vandig injiserbar oppløsning av en blokkopo- lymer av polyoksypropylen/polyoksyetylen, idet oppløsningen er vesentlig fri for antioksydasjonsmiddel og er buffret ved en pH-verdi fra 5,5 til 6,5.
NO951462A 1992-10-19 1995-04-18 Preparat basert på polyoksyetylen-polyoksypropylenblokk kopolymerer og beholder som inneholder preparatet NO951462L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation
PCT/GB1993/002141 WO1994008596A1 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it

Publications (2)

Publication Number Publication Date
NO951462D0 NO951462D0 (no) 1995-04-18
NO951462L true NO951462L (no) 1995-06-13

Family

ID=10723654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951462A NO951462L (no) 1992-10-19 1995-04-18 Preparat basert på polyoksyetylen-polyoksypropylenblokk kopolymerer og beholder som inneholder preparatet

Country Status (19)

Country Link
EP (1) EP0671919A1 (no)
JP (1) JPH08502284A (no)
KR (1) KR950703345A (no)
AU (1) AU674895B2 (no)
BR (1) BR9307268A (no)
CA (1) CA2147889A1 (no)
CZ (1) CZ63395A3 (no)
GB (1) GB9221883D0 (no)
HU (1) HUT75701A (no)
IL (1) IL107313A0 (no)
MX (1) MX9306467A (no)
NO (1) NO951462L (no)
NZ (1) NZ256890A (no)
PL (1) PL308459A1 (no)
SI (1) SI9300545A (no)
SK (1) SK44795A3 (no)
TW (1) TW276183B (no)
WO (1) WO1994008596A1 (no)
ZA (1) ZA937714B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110212047A1 (en) * 2007-08-10 2011-09-01 Synth Rx, Inc. Polymer Therapy for the Treatment of Chronic Microvascular Diseases
US20160235781A1 (en) 2013-10-16 2016-08-18 Mast Therapeutics, Inc. Diuretic induced alterations of plasma volume
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
EP3747448A1 (en) 2014-07-07 2020-12-09 LifeRaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
CN109432511A (zh) * 2018-12-29 2019-03-08 常州乐奥医疗科技股份有限公司 一种温敏型水凝胶及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia

Also Published As

Publication number Publication date
KR950703345A (ko) 1995-09-20
CZ63395A3 (en) 1995-07-12
NZ256890A (en) 1995-10-26
JPH08502284A (ja) 1996-03-12
SK44795A3 (en) 1996-05-08
WO1994008596A1 (en) 1994-04-28
NO951462D0 (no) 1995-04-18
CA2147889A1 (en) 1994-04-28
ZA937714B (en) 1995-04-18
HU9501104D0 (en) 1995-06-28
HUT75701A (en) 1997-05-28
MX9306467A (es) 1994-05-31
SI9300545A (en) 1994-06-30
AU5284293A (en) 1994-05-09
GB9221883D0 (en) 1992-12-02
IL107313A0 (en) 1994-01-25
TW276183B (no) 1996-05-21
PL308459A1 (en) 1995-07-24
BR9307268A (pt) 1999-05-11
AU674895B2 (en) 1997-01-16
EP0671919A1 (en) 1995-09-20

Similar Documents

Publication Publication Date Title
AU7549696A (en) Bioadhesive pharmaceutical composition for the controlled release of active principles
AU7640787A (en) Apparatus for enhancing cell growth, preservation and transport
CA2001618A1 (en) Gestodene-containing agent for transdermal administration
IT8125835A0 (it) Confezione di caffe' in atmosfera evacuata o di gas inerte.
MY109880A (en) Substituted biphenylpyridones
IL90435A0 (en) 4-(quinolin-2-yl-methoxy)phenylacetic acid derivatives,their preparation and pharmaceutical compositions containing them
AU4089189A (en) The use of asymmetric membranes in delivery devices
AU2170788A (en) Eva based multi-layer, heat shrinkable, packaging film and bags made therefrom
ES551459A0 (es) Aparato prensor para apilar una tanda de hojas o laminas
IE873125L (en) Benzimidazole derivatives
ATE176577T1 (de) Konservierungsmittel
NO951462L (no) Preparat basert på polyoksyetylen-polyoksypropylenblokk kopolymerer og beholder som inneholder preparatet
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
DK404589D0 (da) Vakuumemballeret daaseprodukt, og fremgangsmaade til fremstilling af emballagen
CA2023419A1 (en) Vacuum track and pallets
AU4434189A (en) An anti-human immunodeficiency virus composition
AU4429885A (en) Solid medicament formulations containing dihydropyridines
DK0517160T3 (da) Oftalmiske præparater med forlænget frigivelse
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
AU6452190A (en) A process for the preparation of 3-(l-pyroglutamyl)-l- thiazolidine-4-carboxylic acid and its derivatives
AU2234588A (en) Administration of extremely low dosages of dideoxynucleoside analogs for treating or preventing AIDS in subjects
IT1256396B (it) Dispositivo per la difesa da insetti
IT1260469B (it) Macchina inscatolatrice per fiale in particolare del tipo in vetro ad uso medico
ZA973794B (en) Antioxidant medicament.